ElevateBio Announces AlloVir As First Spoke In Its Cell And Gene Therapy Hub

AlloVir Viralym M test tube
AlloVir's lead product candidate is allogeneic T-cell therapy Viralym-M • Source: AlloVir
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business